The prevalence of Parkinson's disease: A systematic review and meta‐analysis
By T. Pringsheim, N. Jetté, A. Frolkis, T. Steeves. Movement Disorders, 2014
2,012 citations recorded by the source corpus.
Subfields: Cellular and Molecular Neuroscience, Neurology
View Paper: https://www.semanticscholar.org/paper/4593494ba5aa96ba3db4b449aee46a88e8175904
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Cellular and Molecular Neuroscience
In Neurology
Citations in the corpus
- MDS research criteria for prodromal Parkinson's disease (2015, background): “0% at age 85.(6,7) If one posits that prodromal PD has approximately a 10-year average duration, this would estimate a”
- The clinical symptoms of Parkinson's disease (2016, background): “It is the second most common neurodegenerative disease worldwide with incidence and prevalence on the rise along with changing population demographics (Pringsheim et al. 2014).”
- Neuroinflammation in Parkinson’s disease and its potential as therapeutic target (2015, background): “Although a variety of possible pathogenetic mechanisms have been proposed over the years, including excessive release of oxygen free radicals during enzymatic dopamine breakdown, impairment of mitochondrial function, loss of trophic support, abnormal kinase activity, disruption of calcium homeostasi”
- The prevalence of posttraumatic stress disorder in pregnancy and after birth: A systematic review and meta-analysis. (2017, neutral): “This is a common problem in the epidemiology of mental health disorders where prevalence often varies widely across studies and countries (Pringsheim et al., 2014).”